Use of genetic markers for identifying the response to...

Details Use of genetic markers for identifying the response to... Use of genetic markers for identifying the response to...

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01)

Patent

CA 2724420

The present invention relates to the use of genetic markers to identify the response to interferon-beta (IFN-beta) treatment in Multiple Sclerosis (MS) patients as well as a method for treating MS patients and kits for genotyping.

La présente invention concerne l'utilisation de marqueurs génétiques permettant d'identifier la réponse au traitement par interféron-bêta (IFN-bêta) chez des patients atteints de sclérose multiple (SM). L'invention porte également sur une méthode permettant de traiter des patients atteints de SM et sur des kits de génotypage.

Affiliated with

Also associated with

Rating

Use of genetic markers for identifying the response to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of genetic markers for identifying the response to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of genetic markers for identifying the response to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1848548